Susanne Wilke
Directeur Général chez Crossbridge International LLC
Profil
Susanne Wilke is the President and Chief Executive Officer of Crossbridge International LLC since 2011.
She was the President, Chief Executive Officer, and Director of Cognoptix, Inc. from 2020 to 2021, and the Chief Executive Officer and Director of Neurotrope, Inc. from 2016 to 2017.
She also worked as a Principal at NGN Capital LLC.
Dr. Wilke completed her undergraduate degree at Loyola University of Chicago, her doctorate at the University of Illinois, and her MBA at the Tuck School of Business at Dartmouth.
Postes actifs de Susanne Wilke
| Sociétés | Poste | Début |
|---|---|---|
| Crossbridge International LLC | Directeur Général | 01/08/2011 |
Anciens postes connus de Susanne Wilke
| Sociétés | Poste | Fin |
|---|---|---|
Cognoptix, Inc.
 Cognoptix, Inc. Hospital/Nursing ManagementHealth Services Cognoptix, Inc. develops a non-invasive and predictive eye scanning test for the early detection and diagnosis of alzheimer's disease. It offers technologies to enable non-invasive quantitative measurements of amyloid aggregates in the eye. The firm also develops combined optical scanning devices and diagnostic agents for clinical, commercial and academic research use. The company was founded by Lee E. Goldstein and Leo T. Chylack Jr in 2001 and is headquartered in Acton, MA. | Directeur Général | 01/10/2021 |
| NEUROTROPE, INC. | Directeur Général | 14/12/2017 |
NGN Capital LLC
 NGN Capital LLC Investment ManagersFinance NGN Capital LLC (NGN Capital) is a venture capital firm founded in 2003 by Kenneth S. Abramowitz and William J. Gedale. The firm is headquartered in New York. | Private Equity Investor | 31/03/2007 |
Formation de Susanne Wilke
| Tuck School of Business at Dartmouth | Masters Business Admin |
| Loyola University of Chicago | Undergraduate Degree |
| University of Illinois | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
NGN Capital LLC
NGN Capital LLC Investment ManagersFinance NGN Capital LLC (NGN Capital) is a venture capital firm founded in 2003 by Kenneth S. Abramowitz and William J. Gedale. The firm is headquartered in New York. | Finance |
Neurotrope, Inc.
 Neurotrope, Inc. Pharmaceuticals: MajorHealth Technology Neurotrope, Inc. is a biopharmaceutical company, which engages in the pre-clinical and clinical development of its product candidates. The company focuses on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease. It also develops bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X and Niemann-Pick Type C. The company was founded on January 11, 2011 and is headquartered in New York, NY. | Health Technology |
| Crossbridge International LLC | |
Cognoptix, Inc.
Cognoptix, Inc. Hospital/Nursing ManagementHealth Services Cognoptix, Inc. develops a non-invasive and predictive eye scanning test for the early detection and diagnosis of alzheimer's disease. It offers technologies to enable non-invasive quantitative measurements of amyloid aggregates in the eye. The firm also develops combined optical scanning devices and diagnostic agents for clinical, commercial and academic research use. The company was founded by Lee E. Goldstein and Leo T. Chylack Jr in 2001 and is headquartered in Acton, MA. | Health Services |